{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:59:36Z","timestamp":1771919976596,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Visceral leishmaniasis (VL) patients are at high risk of acquiring hepatitis B virus (HBV) and hepatitis C virus (HCV) infections during multiple injections and the anti-leishmanial treatment possesses a potential hepatotoxic effect. This systematic review and meta-analysis determined the pooled prevalence of HBV and HCV infections in VL patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO), with the assigned number CRD42024516889, and conducted as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was performed using PubMed, Medline, EMBASE, Google Scholar, Web of Science, and Science Direct databases. Data were extracted using Microsoft Excel and analyzed using STATA version 11.0 software. A random-effects model was used to estimate the pooled effect size of outcome variables across studies with a 95% confidence interval and was displayed in a forest plot. The <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> statistic was used to check for heterogeneity. The presence of publication bias was determined using a funnel plot and Egger\u2019s test with a <jats:italic>p<\/jats:italic> value &amp;lt;0.05 evidence of statistically significant bias.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 216 retrieved records, seven studies were eligible for systematic review and meta-analysis. A total of 937 VL patients were examined, revealing that 105 and 93 were infected with HBV and HCV, respectively. The pooled prevalence of HBV was 16.15% (95% CI: \u22124.10 to 36.39), with a significant heterogeneity (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200991.4%, <jats:italic>p\u2009&amp;lt;<\/jats:italic> 0.001). The combined prevalence of HCV was 13.74% (95% CI: 1.32\u201326.16, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200971.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). The funnel plot (symmetry), and Egger\u2019s test in both HBV (<jats:italic>p<\/jats:italic> value\u2009=\u20090.650) and HCV (<jats:italic>p<\/jats:italic> value\u2009=\u20090.841) revealed no publication bias. In subgroup analysis, high HBV and HCV prevalence was detected in Sudan; 20.64% (95% CI: \u221213.60 to 54.88) and India; 18.26% (95% CI: \u22120.40 to 36.92%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study revealed a high prevalence of both HBV and HCV infections in VL patients. In subgroup analysis, the prevalence of HBV and HCV was high in Sudan and India, respectively. Therefore, screening of VL patients for HBV and HCV, vaccination of VL patients in endemic regions, and collaboration between kala-azar and hepatitis elimination programs are required.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/export_details_pdf.php#page=1.00&amp;amp;gsr=0<\/jats:ext-link>, identifier: CRD42024516889.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2024.1415330","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T08:55:11Z","timestamp":1719305711000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of hepatitis B and C virus infections among visceral leishmaniasis patients: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Muluneh","family":"Assefa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirak","family":"Biset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.17420\/ap6602.248","article-title":"Serological screening of HIV and viral hepatitis revealed low prevalence among visceral leishmaniosis patients in Sudan","volume":"66","author":"Abass","year":"2020","journal-title":"Annal. Parasitol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0008319","DOI":"10.1371\/journal.pntd.0008319","article-title":"Prognostic factors for mortality among patients with visceral leishmaniasis in East Africa: systematic review and meta-analysis","volume":"14","author":"Abongomera","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5144\/0256-4947.2014.143","article-title":"Visceral leishmaniasis-hepatitis B\/C coinfections: a rising necessity to triage patients for treatment","volume":"34","author":"Adam","year":"2014","journal-title":"Ann. Saudi Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1016\/S2214-109X(23)00267-X","article-title":"Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the eastern Mediterranean region: a systematic review and meta-analysis","volume":"11","author":"Aghaei","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e21907","DOI":"10.7759\/cureus.21907","article-title":"Viral hepatitis as a public health concern: A narrative review about the current scenario and the way forward","volume":"14","author":"Bhadoria","year":"2022","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12879-019-3947-x","article-title":"Direct-acting antivirals and visceral leishmaniasis: a case report","volume":"19","author":"Colomba","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s15010-001-1060-7","article-title":"Clinical expression of \u2018silent\u2019hepatitis B virus infection in a patient with visceral leishmaniasis","volume":"29","author":"Coppola","year":"2001","journal-title":"Infection"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/pathogens12070969","article-title":"From infection to death: an overview of the pathogenesis of visceral leishmaniasis","volume":"12","author":"Costa","year":"2023","journal-title":"Pathogens"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref10","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Egger","year":"2008"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0260022","DOI":"10.1371\/journal.pone.0260022","article-title":"Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of Gondar leishmaniasis research and treatment center, Northwest Ethiopia","volume":"16","author":"Endale","year":"2021","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.3399\/bjgp16X684817","article-title":"Low hepatitis B testing among migrants: a cross-sectional study in a UK city","volume":"66","author":"Evlampidou","year":"2016","journal-title":"Br. J. Gen. Pract."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1590\/S0037-86822002000500015","article-title":"Visceral leishmaniasis and B fulminant hepatitis association: case report","volume":"35","author":"Godoy","year":"2002","journal-title":"J. Braz. Soc. Trop. Med."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5772\/intechopen.86359","article-title":"Epidemiology and ecology of leishmaniasis","volume-title":"Current Topics in Neglected Tropical Diseases","author":"Inceboz","year":"2019"},{"key":"ref16","year":"2017"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101504","DOI":"10.1016\/j.cegh.2023.101504","article-title":"Prevalence of HIV infection among visceral leishmaniasis patients in India: a systematic review and meta-analysis","volume":"25","author":"Kaur","year":"2024","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0269250","DOI":"10.1371\/journal.pone.0269250","article-title":"Epidemiology of hepatitis B virus and\/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: a systematic review and meta-analysis","volume":"17","author":"Kenfack-Momo","year":"2022","journal-title":"PLoS One"},{"key":"ref19","first-page":"221","article-title":"The spectrum of HBV\/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management","volume":"28","author":"Konstantinou","year":"2015","journal-title":"Annal. Gastroenterol. Q. Publ. Hellen. Soc. Gastroenterol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jiph.2019.07.026","article-title":"Visceral leishmaniasis in a patient with active HBV\/HDV co-infection","volume":"13","author":"Lupia","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.cgh.2008.04.033","article-title":"High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center","volume":"6","author":"Mathur","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.puhe.2021.11.020","article-title":"Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis","volume":"203","author":"Mehmandoost","year":"2022","journal-title":"Public Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e0257229","DOI":"10.1371\/journal.pone.0257229","article-title":"Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate\/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia","volume":"16","author":"Mengstie","year":"2021","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"021","DOI":"10.17352\/2455-5363.000010","article-title":"Prevalence of hepatitis b, hepatitis c, HIV and malaria co infection among patients infected with visceral leishmaniasis in Gedarif, eastern Sudan","volume":"2","author":"Mohammed","year":"2016","journal-title":"Glob. J. Infect. Dis. Clin. Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12879-020-4935-x","article-title":"Prevalence estimates of human immunodeficiency virus (HIV) infection among visceral leishmaniasis infected people in Northwest Ethiopia: a systematic review and meta-analysis","volume":"20","author":"Mohebali","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e1674","DOI":"10.1002\/hsr2.1674","article-title":"Prevalence of HIV, hepatitis B virus, hepatitis C virus, drug use, and sexual behaviors among street children in Iran: A systematic review and meta-analysis","volume":"6","author":"Nasiri","year":"2023","journal-title":"Health Sci. Rep."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4103\/ajprhc.ajprhc_147_23","article-title":"The frequency of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus co-infections among visceral Leishmaniasis patients and their impact on management","volume":"15","author":"Osman","year":"2023","journal-title":"Asian J. Pharm. Res. Health Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0035-9203(03)80028-7","article-title":"Case report: effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis C","volume":"97","author":"Precone","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mib.2018.07.005","article-title":"The criminal association of Leishmania parasites and viruses","volume":"46","author":"Rossi","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"ref31","first-page":"401","article-title":"Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap\/surveillance mondiale de la leishmaniose: 2019-2020, Une periode de reference pour la feuille de route a l'horizon 2030","volume":"96","author":"Ruiz-Postigo","year":"2021","journal-title":"Wkly Epidemiol. Rec."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/6621199","article-title":"Scoping review of deep learning techniques for diagnosis, drug discovery, and vaccine development in Leishmaniasis","volume":"2024","author":"Sadeghi","year":"2024","journal-title":"Transbound. Emerg. Dis."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00436-021-07139-2","article-title":"Leishmaniasis: where are we and where are we heading?","volume":"120","author":"Sasidharan","year":"2021","journal-title":"Parasitol. Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/microorganisms10101887","article-title":"Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics","volume":"10","author":"Scarpini","year":"2022","journal-title":"Microorganisms"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/00365540050164137","article-title":"Hepatitis B, C and human immunodeficiency virus infections in multiply-injected kala-azar patients in Delhi","volume":"32","author":"Singh","year":"","journal-title":"Scand. J. Infect. Dis."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1201-9712(00)90110-3","article-title":"Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study","volume":"4","author":"Singh","year":"","journal-title":"Int. J. Infect. Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4456-0","article-title":"Magnitude of hepatitis B and C virus infections and associated factors among patients scheduled for surgery at Hawassa university comprehensive specialized hospital, Hawassa City, southern Ethiopia","volume":"12","author":"Taye","year":"2019","journal-title":"BMC. Res. Notes"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect. Dis. Clin."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.35500\/jghs.2020.2.e3","article-title":"Visceral leishmaniasis: a global overview","volume":"2","author":"Wamai","year":"2020","journal-title":"J. Glob. Health Sci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s15010-003-3139-9","article-title":"Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil","volume":"31","author":"Werneck","year":"2003","journal-title":"Infection"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cmi.2023.03.002","article-title":"Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12985-020-01404-z","article-title":"Hepatitis B and hepatitis C prevalence among people living with HIV\/AIDS in China: a systematic review and meta-analysis","volume":"17","author":"Yu","year":"2020","journal-title":"Virol. J."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1415330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T08:55:19Z","timestamp":1719305719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1415330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":42,"alternative-id":["10.3389\/fmicb.2024.1415330"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1415330","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"article-number":"1415330"}}